Increased urinary atrial natriuretic peptide-like immunoreactivity excretion but decreased plasma atrial natriuretic peptide concentration in patients with hyperosmolar-hyperglycemic nonketotic syndrome

Diabetes Care

Volumn 22, Issue 7, 1999, Pages 1181-1185

  Shin, Shyi Jang ^a   Lee, Yau Jiunn ^a   Hsiao, Pi Jung ^a   Tsai, Juei Hsiung ^a  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; ATRIAL NATRIURETIC FACTOR; CREATININE; ELECTROLYTE; GLUCOSE; INSULIN; RENIN; UREA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE URINE LEVEL; DEHYDRATION; DIABETES MELLITUS; ELECTROLYTE BALANCE; HUMAN; HYPERGLYCEMIA; HYPEROSMOLALITY; IMMUNOREACTIVITY; PLASMA RENIN ACTIVITY; RADIOIMMUNOASSAY; UREA NITROGEN BLOOD LEVEL; URINARY EXCRETION;

ANALYSIS OF VARIANCE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; BLOOD UREA NITROGEN; CREATININE; DIABETES MELLITUS, TYPE 2; HUMANS; HYPERGLYCEMIC HYPEROSMOLAR NONKETOTIC COMA; HYPOGLYCEMIC AGENTS; MIDDLE AGED; RADIOIMMUNOASSAY; REFERENCE VALUES; RENIN;

EID: 0033016934     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.7.1181     Document Type: Article

References (34)

1. Luft FC, Sterzel RB, Lang RE, Trabold EM, Veelken R, Ruskoaho H, Gao Y, Ganten D, Unger T: Atrial natriuretic factor determinations and chronic sodium homeostasis. Kidney Int 29:1004-1010, 1986
2. Lattion AL, Aubert JF, Fluckiger JP, Nussberger J, Waeber B, Brunner HR: Effect of sodium intake on gene expression and plasma levels of ANF in rats. Am J Physiol 255:H245-H249, 1988
3. Nakayama K, Ohkubo H, Hirose T, Inayama S, Nakanishi S: mRNA sequence for human cardiodilatin: artrial natriuretic factor precursor and regulation of precursor mRNA in rat atria. Nature 310:699-701, 1984
4. Takayanagi R, Tanaka I, Maki M, Inagami T: Effects of changes in water-sodium balance on levels of atrial natriuretic factor messenger RNA and peptide in rats. Life Sci 36: 1843-1848, 1985
5. Ritter D, Needleman P, Greenwald JE: Synthesis and secretion of an atriopeptin-like protein in rat kidney cell culture. J Clin Invest 87:208-212, 1991
6. Ramirez G, Saba SR, Dietz JR, Vesely DL: Immunocytochemical localization of proANF 1-30, proANF 31-67 and atrial natriuretic factor in the kidney. Kidney Int 41:334-341, 1992
7. Greenwald JE, Needleman P, Wikins M, Schreiner GF: Renal synthesis of atriopeptin-like protein in physiology and pathophysiology. Am J Physiol 260: F602-F607, 1991
8. Shin SJ, Lee YJ, Tan MS, Hsieh TJ, Tsai JH: Increased atrial natriuretic peptide mRNA expression in the kidney of diabetic rats. Kidney Int 51:1100-1105, 1997
9. Lee YJ, Shin SJ, Tan MS, Hsieh TJ, Tsai JH: Increased renal atrial natriuretic peptide synthesis in rats with deoxycorticosterone acetate-salt treatment. Am J Physiol 271: F779-F789, 1996
10. Shin SJ, Wen JD, Chen IH, Lai FJ, Hsieh MJ, Hsieh TJ, Tan MS, Tsai JH: Increased renal ANP synthesis but decreased or unchanged cardiac ANP synthesis in water-deprived and salt-restricted rats. Kidney Int 54:1617-1625, 1998
11. Allen TJ, Cooper ME, O'Brien RC, Bach LA, Jackson B, Jerums G: Glomerular filtration rate in streptozotocin-induced diabetic rats: role of exchangeable sodium, vasoactive hormones, and insulin therapy. Diabetes 39:1182-1190, 1990
12. Ortola F, Ballermann BJ, Anderson S, Mendez RE, Brenner BM: Elevated plasma atrial natriuretic peptide levels in diabetic rats: potential mediator of hyperfiltration. J Clin Invest 80:670-674, 1987
13. Matsubara H, Mori Y, Yamamoto J, Inada M: Diabetes-induced alterations in atrial natriuretic peptide gene expression in Wistar-Kyoto and spontaneously hypertensive rats. Circ Res 67:803-813, 1990
14. Perico N, Benigni A, Gabanelli M, Piccinelli A, Rog M, Riva CD, Remuzzi G: Atrial natriuretic peptide and prostacyclin synergistically mediate hyperfiltration and hyperperfusion of diabetic rats. Diabetes 41:533-538, 1992
15. Bell GM, Bernstein RK, Laragh JH, Atlas SA, James GD, Pecker MS, Sealey JE: Increased plasma atrial natriuretic factor and reduced plasma renin in patients with poorly controlled diabetes mellitus. Clin Sci 77: 177-182, 1989
16. Tulassay T, Rascher W Körner A, Miltenyi M: Atrial natriuretic peptide and other vasoactive hormones during treatment of severe diabetic ketoacidosis in children. J Pediatr 111:329-334, 1987
17. Kamoi K, Ishibashi M, Yamaji T: Thirst and plasma levels of vasopressin, angiotensin II and atrial natriuretic peptide in patients with non-insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 11:195-202, 1991
18. Ennis ED, Stahl EJB: The hyperosmolar hyperglycemic syndrome. Diabetes Rev 2:115-126, 1994
19. Schulz-Knappe P, Forssmann K, Herbst F, Hock D, Pipkorn R, Forssmann WG: Isolation and structural analysis of "Urodilatin," a new peptide of the cardiodilatin-(ANP)-family, extracted from human urine. Klin Wochenschr 66:752-759, 1988
20. Drummer C, Fiedler F, Bub A, Kleefeld D, Dimitriades E, Gerzer R, Forssmann WG: Development and application of a urodilatin (CDD/ANP-95-126)-specific radioimmuno-assay. Pflugers Arch 423:372-377, 1993
21. Herten M, Lenz W, Gerzer R, Drummer C: The renal natriuretic peptide urodilatin is present in human kidney. Nephrol Dial Transplant 13:2529-2535, 1998
22. Lenz W, Herten M, Gerzer R, Drummer C: Regulation of natriuretic peptide (urodilatin) release in a human kidney cell line. Kidney Int 55:91-99, 1999
23. Brenner BM, Ballermann BJ, Gunning ME, Zeidel ML: Diverse biological actions of atrial natriuretic peptide. Physiol Rev 70:665-699, 1990
24. Koler K, Goeddel DV: Molecular biology of natriuretic peptides and their receptors. Circulation 86:1081-1088, 1992
25. Gagelmann M, Hock D, Forssmann WG: Urodilatin (CDD/ANP-95-126) is not biologically inactivated by a peptidase from dog kidney cortex membranes in contrast to atrial natriuretic peptide/cardiodilatin (α-hANP/CDD-99-126). FEBS Lett 233: 249-254, 1988
26. Solc J, Bauer K, Timnik A, Solcova A, Dohlemann C, Strom TM, Weil J: Combination of high-performance liquid chromatography and radioimmunoassay for the measurement or urodilatin and α-hANP in the urine of healthy males. Life Sci 48: 2451-2456, 1991
27. Suzuki Y, Suzuki H, Ohtake R, Tsuchiya T, Muramatsu H, Hashigami Y, Kobori H, Shimoda S-I: Plasma and urine concentrations of atrial natriuretic peptide in patients with diabetes mellitus. Pancreas 3:404-408, 1988
28. Miltenyi M, Tulassay T, Szabo A, Korner A, Seyberth HW: Urinary prostaglandins in hyperglycaemic ketoacidosis of type I diabetes mellitus. Pediatric Nephrology 4: 44-47, 1990
29. Yared A, Kon V, Ichikawa I: Mechanism of preservation of glomerular perfusion and filtration during acute extracellular fluid volume depletion: importance of intrarenal vasopressin-prostaglandin interaction for protecting kidneys from constrictor action of vasopressin. J Clin Invest 75:1477-1487, 1985
30. Watkins L Jr, Burton JA, Haber E, Cart JR, Smith FW, Barger AC: The renin-angiotensin-aldosterone system in congestive failure in conscious dogs. J Clin Invest 57:1606-1617, 1976
31. Henrich WL, Anderson RJ, Berns AS, McDonald KM, Paulsen PJ, Berl T, Schrier RW: The role of renal nerves and prostaglandins in control of renal hemodynamics and plasma renin activity during hypotensive hemorrhage in the dog. J Clin Invest 61:744-750, 1978
32. Siragy HM, Carey RM: The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats. J Clin Invest 100:264-269, 1997
33. Siragy HM, Carey RM: The subtype-2 (AT2) angiotensin receptor regulates renal cyclic guanosine 3′, 5′-monophosphate and AT1 receptor-mediated prostaglandin E2 production in conscious rats. J Clin Invest 97:1978-1982, 1996
34. Hirata Y, Hayakawa H, Kakoki M, Tojo A, Suzuki E, Nagata D, Kimura K, Goto A, Kikuchi K, Nagano T, Hirobe M, Omata M: Receptor subtype for vasopressin-induced release of nitric oxide from rat kidney. Hypertension 29:58-64, 1997